Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
With a market cap of 1.38B, Replimune(REPL) trades at $14.59. The stock has a price-to-earnings ratio of -4.28.
During the trading session on 2026-08-21, Replimune(REPL) shares reached a daily high of $14.65 and a low of $13.81. At a current price of $14.59, the stock is +5.6% higher than the low and still -0.4% under the high.
Trading volume for Replimune(REPL) stock has reached 295.95K, versus its average volume of 5.02M.
Over the past 52 weeks, Replimune(REPL) stock has traded between a high of $15.71 and a low of $1.50.
Over the past 52 weeks, Replimune(REPL) stock has traded between a high of $15.71 and a low of $1.50.
REPL News
New insider activity at Replimune Group ( (REPL) ) has taken place on August 19, 2026. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with...
...
Replimune Group, Inc. (NASDAQ: REPL) is facing a federal securities lawsuit alleging that investors were not told key facts about regulatory weaknesses in the c...
Analyst ratings
100%
of 7 ratingsMore REPL News
Replimune Group (REPL) drew fresh attention after the FDA granted accelerated approval for TUDRIQEV in combination with nivolumab in advanced cutaneous melanoma...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.